Ratings by Barclays (James Gordon)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/6/2026 GlaxoSmithKline GSK Downgrade Underweight
(Equalweight)
49.02
(54.51)
11.2% Details